Basic Information
Basic information for SNHG17-257-11aa
Peptide Name SNHG17-257-11aa
Genome Position chr20:38435203-38435235[-]
Species Human
Peptide Sequence MVGSTLTIGGN
Peptide Length 11
Unique No (SNHG17-201-11aa,SNHG17-205-11aa,SNHG17-208-11aa,SNHG17-212-11aa,SNHG17-222-11aa,SNHG17-224-11aa,SNHG17-229-11aa,SNHG17-232-11aa,SNHG17-237-11aa,SNHG17-246-11aa,SNHG17-247-11aa,SNHG17-259-11aa,SNHG17-262-11aa,SNHG17-266-11aa,SNHG17-268-11aa,SNHG17-277-11aa,SNHG17-278-11aa,SNHG17-279-11aa,SNHG17-281-11aa)
Grand Average of Hydropathicity 0.6818
Relative Molecular Mass 1229.44
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000196756;SNHG17
Transcript ID/Name ENST00000664073;SNHG17-257
Transcript Length 1154
Coding Ability 0.286
DNA Sequence Corresponding to Peptide ATGGTCGGCTCCACTCTCACCATCGGGGGAAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :